Investigational drug · Phase 3
IS-001
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Ureter Injury.
Phase 3Last checked: Nov 19, 2026Latest source record: Jan 15, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
5
Any phase or sponsor naming "IS-001"
First trial start
2024
Jan 17, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "IS-001", any sponsor or status.
Conditions studied
As listed on its trial records.
- Ureter Injury
Largest trials
Live from ClinicalTrials.gov: studies naming "IS-001" as an intervention, largest first.
- IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological SurgeryPivotal-lookingCompleted
Intuitive SurgicalIndustry
NCT05954767 · 189 participants · Start Jan 17, 2024 · Primary completion Jan 31, 2025
Drug: IS-001 · For: Ureter Injury
Sites: Newport Beach, California; Miami, Florida; Orlando, Florida · 8 sites in all
- IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal SurgeryPivotal-lookingRecruiting
Intuitive SurgicalIndustry
NCT07346066 · 146 participants (planned) · Start May 14, 2026 · Primary completion Apr 30, 2027
Drug: filricianine · For: Ureter Injury
Sites: Newport Beach, California; New Haven, Connecticut; Orlando, Florida · 9 sites in all
- A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic HysterectomyCompleted
Intuitive SurgicalIndustry
NCT03937505 · 94 participants · Start May 28, 2019 · Primary completion Jul 8, 2021
Drug: IS-001; No treatment · For: Ureter Injury
Sites: Washington D.C., District of Columbia; Austin, Texas; El Paso, Texas
Intuitive SurgicalIndustry
NCT03006237 · 24 participants · Start Dec 2016 · Primary completion Dec 2017
Drug: IS-001 · For: Hysterectomy; Surgery
Sites: El Paso, Texas
- A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal SurgeryCompleted
Intuitive SurgicalIndustry
NCT05769257 · 12 participants · Start Jun 14, 2023 · Primary completion Mar 18, 2024
Drug: IS-001 · For: Ureter Injury
Sites: Austin, Texas; Tacoma, Washington
Newest research
PubMed records naming it or its code names, newest first.
- [Development of Intraoperative Near-infrared Fluorescent Ureteral Imaging Agent to Prevent Iatrogenic Ureteral Injury].
Teranishi K · Yakugaku Zasshi 2025
- Hydrothermal Growth and Orientation of LaFeO3 Epitaxial Films.
Xian G, Zheng T, Tao Y, et al. · Materials (Basel) 2024
- Sustaining Quality of Life with Education-Based Treatment for Hypertension Patients During COVID-19 Adaptation.
Kristinawati B, Mardana NW, Wijayanti NWD · J Holist Nurs 2024
- Untangling product selectivity on clean low index rutile TiO2 surfaces using first-principles calculations.
Malik AS, Fredin LA · Phys Chem Chem Phys 2023
- C-Axis Textured, 2-3 μm Thick Al0.75Sc0.25N Films Grown on Chemically Formed TiN/Ti Seeding Layers for MEMS Applications.
Cohen A, Cohen H, Cohen SR, et al. · Sensors (Basel) 2022
- Thickness Effect on the Solid-State Reaction of a Ni/GaAs System.
Rabhi S, Oueldna N, Perrin-Pellegrino C, et al. · Nanomaterials (Basel) 2022
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.